What is the recommended treatment for pediatric Group A Streptococcal (GAS) infections?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 12, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

The recommended treatment for pediatric Group A Streptococcal (GAS) infections is penicillin or amoxicillin for 10 days.

Treatment Options

  • For individuals without penicillin allergy, the following options are available:
    • Penicillin V, oral: 250 mg twice daily or 3 times daily for children, and 250 mg 4 times daily or 500 mg twice daily for adolescents and adults, for 10 days 1
    • Amoxicillin, oral: 50 mg/kg once daily (max = 1000 mg) or 25 mg/kg (max = 500 mg) twice daily, for 10 days 1
    • Benzathine penicillin G, intramuscular: 600,000 U for children <27 kg and 1,200,000 U for children ≥27 kg, as a single dose 1
  • For individuals with penicillin allergy, the following options are available:
    • Cephalexin, oral: 20 mg/kg/dose twice daily (max = 500 mg/dose), for 10 days 1
    • Clindamycin, oral: 7 mg/kg/dose 3 times daily (max = 300 mg/dose), for 10 days 1
    • Azithromycin, oral: 12 mg/kg once daily (max = 500 mg), for 5 days 1

Important Considerations

  • Antimicrobial therapy should be initiated as soon as possible after diagnosis is confirmed by culture or rapid antigen detection test (RADT) 1
  • Early initiation of antimicrobial therapy results in faster resolution of signs and symptoms 1
  • Therapy can be safely postponed for up to 9 days after the onset of symptoms and still prevent the occurrence of acute rheumatic fever 1
  • Penicillin remains the treatment of choice due to its proven efficacy, safety, narrow spectrum, and low cost 1

From the Research

Recommended Treatment for Pediatric Group A Streptococcal (GAS) Infections

The recommended treatment for pediatric Group A Streptococcal (GAS) infections is primarily focused on preventing complications and reducing symptom duration.

  • The first-line therapy for streptococcal pharyngitis is a 10-day course of penicillin V, usually given 2 or 3 times per day 2.
  • Alternative treatments include other penicillins, macrolides, and cephalosporins, with cephalosporins potentially offering higher bacteriologic eradication rates than penicillin V 2.
  • A 5-day dosing schedule of third-generation cephalosporins, such as cefdinir and cefpodoxime proxetil, may increase adherence to the full course of therapy and is preferred by children due to its palatability 2.
  • However, recent studies suggest that antibiotics may have a limited impact on the duration of fever and the intensity of pain in children with streptococcal pharyngitis, supporting a more judicious approach to antibiotic prescriptions 3.
  • Amoxicillin or penicillin are recommended for children who are likely to have GAS pharyngitis based on history or physical examination, with a throat swab and positive test results 4.

Considerations for Treatment

  • The use of antibiotics in treating GAS pharyngitis is debated, with some studies suggesting that the benefits of antibiotics in preventing complications are limited 3.
  • The primary justification for antibiotic use remains the reduction of symptoms, but the results of a randomized, multicenter, double-blind, non-inferiority trial suggest that a placebo may be non-inferior to amoxicillin in reducing fever duration 3.
  • The optimal duration of antibiotic therapy is still uncertain, especially given the current peak in streptococcal infections 5.
  • In severe cases of GAS infection, such as sepsis, IVIG and clindamycin may be used, but their use is not universally recommended 6.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.